CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 159 enrolled
Drug / intervention
Menstrual Blood Analysis (Menstrual Blood Analysis)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03638427
NCT03638427N/ACompleted
CompareCT.gov

Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood

Stanford University·observational·Posted Aug 20, 2018·Updated May 28, 2024

In Brief

An observational study evaluating Menstrual Blood Analysis (Menstrual Blood Analysis) for HPV - Anogenital Human Papilloma Virus Infection. Completed, enrolled 159 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other words, can the investigators detect the high risk strains of the human papilloma virus (HPV) that are associated with cervical cancer in self-collected menstrual blood, as an alternative to collecting vaginal swabs.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHPV - Anogenital Human Papilloma Virus Infection
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 20, 2018
Enrollment StartJan 1, 2019
Primary CompletionOct 11, 2022
Study CompletionNov 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 7.9 years ago

Interventions

Menstrual Blood Analysis (Menstrual Blood Analysis)other

We will be testing women's menstrual blood to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood from a menstrual pad.